MiR-378a-5p通过LRP8/β-catenin轴对CRC产生辐射敏感化作用
Guolin Hu1, Pengbiao Che2, Ling Deng1
1Department of Oncology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, China.
Cancer biology & therapy
|February 23, 2024
概括
微RNA-378a-5p (miR-378a-5p) 通过向LRP8和调节β-catenin通路来增强结直肠癌 (CRC) 的辐射敏感性. 恢复miR-378a-5p可能为克服CRC放射电阻提供一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 辐射疗法 辐射疗法
背景情况:
- 微RNAs (miRNAs) 在瘤辐射敏感性中起着至关重要的作用.
- 在结直肠癌 (CRC) 中,miR-378a-5p的表达显著下调.
研究的目的:
- 研究miR-378a-5p在结肠直肠癌中的作用.
- 探索miR-378a-5p对CRC辐射敏感性的影响.
主要方法:
- 在CRC组织和细胞系中分析miR-378a-5p的表达.
- 生物信息学,双露西法酶记者测定和RT-qPCR用于识别miR-378a-5p目标.
- 在体外和体内实验中评估CRC细胞在miR-378a-5p调节和LRP8向后的辐射敏感性.
主要成果:
- 下调的miR-378a-5p与晚期CRC阶段和差异化相关.
- miR-378a-5p上调增强CRC辐射敏感性,通过促进细胞亡和通过LRP8/β-catenin轴抑制扩散.
- 沉默LRP8 (siLRP8) 模仿了miR-378a-5p的辐射敏感化作用.
结论:
- miR-378a-5p通过LRP8/β-catenin通路在CRC中表现出放射敏感化作用.
- miR-378a-5p/LRP8/β-catenin轴代表了克服结直肠癌中放射电阻的潜在治疗目标.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


